Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Herbert J. Zeh"'
Autor:
MaryJoe Rice, Melissa E. Hogg, Herbert J. Zeh, Amer H. Zureikat, Sarwat B. Ahmad, Cecilia Chang
Publikováno v:
The Journal of surgical research. 267
A virtual reality (VR) curriculum performed on the da Vinci Simulation System (DVSS) was previously shown to be effective in training fellows. The dV-Trainer is a separate platform with similar features to the da Vinci console, but its efficacy and u
Autor:
Stefanie C. Altieri Dunn, Melissa E. Hogg, Herbert J. Zeh, Amr Al-abbas, Amer H. Zureikat, Devin Rogers, Jeffrey D. Borrebach, Vernissia Tam
Publikováno v:
The Journal of surgical research. 235
Background Over the past 5 y, robotic surgery has expanded within general surgery, especially in regard to hernia repairs. We aimed to evaluate the outcomes of the early experience of over 300 consecutive robotic inguinal hernia repairs performed in
Autor:
Nick Cheh, Daolin Tang, Reginald Anunobi, Michael T. Lotze, Rui Kang, Tara J. Loux, Brian A. Boone, Herbert J. Zeh
Publikováno v:
The Journal of surgical research. 226
Background Inflammation promotes the growth and survival of malignant cells. Inflammation within the tumor microenvironment is a result of damage-associated molecular patterns released by dead or dying cells that provide survival signals to the surro
Autor:
Kenneth K. Lee, Melissa E. Hogg, Amer H. Zureikat, Herbert J. Zeh, Mazen S. Zenati, Stacy J. Kowalsky, Jennifer Steve
Publikováno v:
The Journal of surgical research. 221
Background Ketorolac (Toradol), a commonly used nonselective nonsteroidal anti-inflammatory drug (NSAID) in the postoperative period, has been associated with increased risk of anastomotic leak after colon resection. The effect of postoperative NSAID
Autor:
Jennifer Steve, Sharon Winters, Amer H. Zureikat, Cindy Valko, Shira Abberbock, Melissa E. Hogg, Herbert J. Zeh, Suzanne Schiffman
Publikováno v:
The Journal of surgical research. 202(2)
The purpose of this study was to evaluate the impact of a multidisciplinary clinic (MDC) on the treatment of pancreatic ductal adenocarcinoma. We hypothesized that an MDC would improve trial participation, multimodality therapy, neoadjuvant therapy,